268 results on '"Lee, Yoo-Young"'
Search Results
2. Analgesic efficacy of erector spinae plane block in patients undergoing major gynecologic surgery: A randomized controlled study
3. Advantages of laparoscopy in gynecologic surgery in elderly patients
4. Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction
5. Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus–Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern
6. The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression
7. A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer
8. Ten-year survival impact of FDA warning on power morcellation in occult uterine leiomyosarcoma diagnosed after minimally invasive surgery
9. Feasibility of articulating laparoscopic instrument in laparoscopic adnexectomy: a multinational prospective observational study
10. Transition and prognostic implications of 2009 to 2023 FIGO staging in endometrial cancer: a retrospective cohort study from stage I to IIIA
11. Feasibility of barbed suture in laparoscopic gynecologic oncologic surgery
12. Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy
13. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer
14. Initial experience with the enhanced recovery after surgery (ERAS) protocols in gynecologic surgery at an urban academic tertiary medical center
15. Community-based visiting healthcare personnels’ capacity in elderly oral health care and the effectiveness of group oral health education: a pilot study
16. Case study of a long-term care resident with oral health problem
17. Adverse Effect of the Duration of Antibiotic Use Prior to Immune Checkpoint Inhibitors on the Overall Survival of Patients with Recurrent Gynecologic Malignancies
18. Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy
19. The first successful uterus transplantation in Korea: from a longing wish to become a mother
20. TP017/#812 A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04)
21. TP003/#1557 An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)
22. PO001/#381 Is minimally invasive surgery safe for cervical cancer patients with a diameter of less than 2 cm? (MISAFE): gynecologic oncology research investigators collboration study (GORILLA-1003)
23. TP018/#822 A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer
24. EP011/#717 Prediction of chemotherapy response with liquid biopsy of body fluid from patients with gynecologic cancer
25. EP128/#505 Impact of different adjuvant treatment approaches on survival in high-risk endometrial carcinoma: a multicenter study
26. EP012/#719 Genome-wide cell-free DNA analysis algorithms for early detection and prediction of prognosis of ovarian cancer
27. TP007/#1383 A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
28. EP134/#1505 Dostarlimab monotherapy in mismatch repair deficient/microsatellite instability-high advanced or recurrent endometrial cancer in the Korean expanded access program
29. EP256/#833 Retrospective analysis comparing the survival outcome of niraparib and olaparib in advanced ovarian cancer patients
30. EP271/#204 The anti-cancer effects of AZD4547 on ovarian cancer cells: differential responses based on FGF19 and c-Met expressions
31. SO012/#773 Comparison the outcomes of large bowel surgery during maximal cytoreductive surgery for advanced ovarian cancer between gynecologic oncology specialist and general surgeon: gorilla-3006
32. EP258/#917 Recurrence-free survival and overall survival in early-stage ovarian cancer considering homologous recombination deficiency(HRD) status
33. EP370/#835 Diagnostic accuracy of cytology test in HPV-independent cervical adenocarcinoma
34. PR077/#690 Gynecologic oncologists’ practice patterns and associated barriers toward palliative-hospice care: a survey of the Korean gynecologic oncology group
35. Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004)
36. Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003)
37. To degas or not to degas? The effectiveness of pharmaceuticals in reducing the impact of bowel volume variations during liver SBRT treatment
38. ASO Visual Abstract: Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity-Score-Matching Study in Korea and Taiwan
39. Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001)
40. Risk of burnout, psychological growth, longevity of career and making sense of Covid‐19 in senior Australian radiation oncologists
41. Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial
42. The effect of adding chewing gum to oral carbohydrates on preoperative anxiety scores in women undergoing gynecological surgery: A randomized controlled study
43. A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)
44. Supplementary Figure 2 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
45. Supplementary Figure 4 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
46. Supplementary Figure 2 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
47. Supplementary Figure 1 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
48. Supplementary Figure 3 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
49. Supplementary Figure 5 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
50. Supplementary Table 1 from Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.